This new report from Venture Planning Group contains 233 pages, 15 tables, and presents a comprehensive analysis of the Japanese hospital hematology and flow cytometry markets, including:
Major issues pertaining to the Japanese hematology and flow cytometry practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next ten years.
Review of current instrumentation technologies, and a feature comparison
of high-, medium-, and low-volume/POC analyzers.
Profiles of major current and emerging suppliers, including their sales, product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements, and business strategies.